Stockreport

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 [Yahoo! Finance]

Vincerx Pharma, Inc.  (VINC) 
PDF The company has seen encouraging safety, efficacy, and tolerability results in the study, with one patient achieving a complete remission. To focus resources on VIP943, [Read more]